Liso-Cel Cost-Effective for Second-Line Relapsed/Refractory Lymphoma
Liso-cel ICER was $99,669 per QALY from health care sector perspective, $68,212 per QALY from a societal perspective
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.